P21860

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession ERBB3_HUMAN; P21860;
Entrez ID 2065
GenBank Protein ID NM_001005915.1; NM_001982.3;
GenBank Nucleotide ID NP_001005915.1; NP_001973.2;
Protein Name Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
Gene Name ERBB3; HER3
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionTyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is activated by it; ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778). May also be activated by CSPG5 (PubMed:15358134).
Sequence
(Fasta)
MRANDALQVL GLLFSLARGS EVGNSQAVCP GTLNGLSVTG DAENQYQTLY KLYERCEVVM 60
GNLEIVLTGH NADLSFLQWI REVTGYVLVA MNEFSTLPLP NLRVVRGTQV YDGKFAIFVM 120
LNYNTNSSHA LRQLRLTQLT EILSGGVYIE KNDKLCHMDT IDWRDIVRDR DAEIVVKDNG 180
RSCPPCHEVC KGRCWGPGSE DCQTLTKTIC APQCNGHCFG PNPNQCCHDE CAGGCSGPQD 240
TDCFACRHFN DSGACVPRCP QPLVYNKLTF QLEPNPHTKY QYGGVCVASC PHNFVVDQTS 300
CVRACPPDKM EVDKNGLKMC EPCGGLCPKA CEGTGSGSRF QTVDSSNIDG FVNCTKILGN 360
LDFLITGLNG DPWHKIPALD PEKLNVFRTV REITGYLNIQ SWPPHMHNFS VFSNLTTIGG 420
RSLYNRGFSL LIMKNLNVTS LGFRSLKEIS AGRIYISANR QLCYHHSLNW TKVLRGPTEE 480
RLDIKHNRPR RDCVAEGKVC DPLCSSGGCW GPGPGQCLSC RNYSRGGVCV THCNFLNGEP 540
REFAHEAECF SCHPECQPME GTATCNGSGS DTCAQCAHFR DGPHCVSSCP HGVLGAKGPI 600
YKYPDVQNEC RPCHENCTQG CKGPELQDCL GQTLVLIGKT HLTMALTVIA GLVVIFMMLG 660
GTFLYWRGRR IQNKRAMRRY LERGESIEPL DPSEKANKVL ARIFKETELR KLKVLGSGVF 720
GTVHKGVWIP EGESIKIPVC IKVIEDKSGR QSFQAVTDHM LAIGSLDHAH IVRLLGLCPG 780
SSLQLVTQYL PLGSLLDHVR QHRGALGPQL LLNWGVQIAK GMYYLEEHGM VHRNLAARNV 840
LLKSPSQVQV ADFGVADLLP PDDKQLLYSE AKTPIKWMAL ESIHFGKYTH QSDVWSYGVT 900
VWELMTFGAE PYAGLRLAEV PDLLEKGERL AQPQICTIDV YMVMVKCWMI DENIRPTFKE 960
LANEFTRMAR DPPRYLVIKR ESGPGIAPGP EPHGLTNKKL EEVELEPELD LDLDLEAEED 1020
NLATTTLGSA LSLPVGTLNR PRGSQSLLSP SSGYMPMNQG NLGESCQESA VSGSSERCPR 1080
PVSLHPMPRG CLASESSEGH VTGSEAELQE KVSMCRSRSR SRSPRPRGDS AYHSQRHSLL 1140
TPVTPLSPPG LEEEDVNGYV MPDTHLKGTP SSREGTLSSV GLSSVLGTEE EDEDEEYEYM 1200
NRRRRHSPPH PPRPSSLEEL GYEYMDVGSD LSASLGSTQS CPLHPVPIMP TAGTTPDEDY 1260
EYMNRQRDGG GPGGDYAAMG ACPASEQGYE EMRAFQGPGH QAPHVHYARL KTLRSLEATD 1320
SAFDNPDYWH SRLFPKANAQ RT 1343

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationBreast cancer/tumor/carcinomaP11389077
[Reference]: p85-sErbB3 inhibits HRG-induced phosphorylation of ErbB2, ErbB3, and ErbB4 in breast carcinoma-derived cell lines and can also block HRG-stimulated activation of mitogen-activated protein kinase, Akt, and association of ErbB3 with the phosphatidylinositol 3'-kinase p85 regulatory subunit.
2PhosphorylationHepatocellular carcinoma/Hepatocarcinoma/Hepatomacell lineP21246584
[Reference]: Phosphorylation of ERBB3 could be induced by conditioned media of HCC cells and abolished by the pretreatment of conditioned media with anti-NRG antibodies or by the silencing of the endogenous NRG expression of the donor HCC cells
3PhosphorylationOvarian cancer/carcinomaU22841590
[Reference]: The increase in HER3 phosphorylation was detected in well-established ovarian cancer cell lines which originate from patients previously treated with these chemotherapeutic drug

※ Disease Cross-ref Annotation

DatabaseAnnotation
Cancer Gene Census
colon, gastric, head and neck, bladder, skin
CTD (Curated)
(count: 8)
(view all)
MESH:D001943 ; Breast Neoplasms
MESH:D018450 ; Disease Progression
MESH:D005706 ; Gallbladder Neoplasms
MESH:C564369 ; Lethal Congenital Contracture Syndrome 2
MESH:D008175 ; Lung Neoplasms
MESH:C538339 ; Nasopharyngeal carcinoma
DisGeNet (Curated)
(count: 28)
(view all)
C0003886; Arthrogryposis
C0005586; Bipolar Disorder
C0011570; Mental Depression
C0013604; Edema
C0016978; gallbladder neoplasm
C0020224; Polyhydramnios
HGMD
(count: 1)
CS073473; Contracture syndrome type 2; Splicing
GWASdb
(count: 9)
(view all)
rs34379766; Obesity-related traits; obesity
rs7971751; Asthma; asthma
rs877636; Polycystic ovary syndrome; polycystic ovary syndrome
rs2292239; Type 1 diabetes; type 1 diabetes mellitus
rs2292239; Multiple complex diseases; Null
rs2292239; Type 1 diabetes autoantibodies; type 1 diabetes mellitus

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 36)
(view all)
1054      LLSPSSGYMPMNQGN     dbPAF
1094      MPRGCLASESSEGHV     dbPAF
1096      RGCLASESSEGHVTG     dbPAF
1097      GCLASESSEGHVTGS     dbPAF
1104      SEGHVTGSEAELQEK     dbPAF
1123      RSRSRSRSPRPRGDS     dbPAF
Methylation
(count: 1)
736       IPEGESIKIPVCIKV     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource
E7ESA6P21860HPRD
E9PNP0P21860MINT
O00459P21860HPRD; MINT
O14511P21860HPRD
O43374P21860HPRD; IntAct; MINT
O43639P21860MINT
O60674P21860MINT
O60880P21860MINT
O75553P21860MINT
P00519P21860MINT
P00533P21860HPRD; IntAct
P01133P21860HPRD
P04626P21860HPRD; IntAct
P08631P21860MINT
P11362P21860MINT
P12931P21860MINT
P15498P21860MINT
P15941P21860HPRD
P16333P21860MINT
P16591P21860MINT
P19174P21860MINT
P20936P21860MINT
P21333P21860HPRD
P21860P21860HPRD; DIP; IntAct
P21860P27701HPRD
P21860P27986HPRD; DIP; IntAct; MINT
P21860P29353MINT;HPRD
P21860P40189HPRD
P21860P41240MINT
P21860P42336IntAct
P21860P42681MINT
P21860P42684MINT
P21860P43403MINT
P21860P43405MINT
P21860P46108MINT
P21860P46109MINT
P21860P49798HPRD
P21860P50052HPRD
P21860P52333MINT
P21860P52735MINT
P21860P52757MINT
P21860P62993HPRD; MINT
P21860Q00535HPRD
P21860Q02297DIP;IntAct;HPRD; DIP
P21860Q07889HPRD
P21860Q08881MINT
P21860Q13671MINT
P21860Q13882HPRD; MINT
P21860Q14289HPRD
P21860Q14451HPRD; MINT
P21860Q15185HPRD
P21860Q15303HPRD; IntAct
P21860Q4VC44IntAct;HPRD
P21860Q5TEW3MINT
P21860Q63HR2MINT
P21860Q68CZ2MINT
P21860Q8IZW8MINT
P21860Q92529MINT
P21860Q92569MINT
P21860Q9H4P4HPRD
P21860Q9UBN7IntAct
P21860Q9UKW4MINT
P21860Q9ULJ1IntAct;HPRD
P21860Q9UN19MINT
P21860Q9UQ80HPRD; IntAct
P21860Q9UQQ2MINT